Memantine Hydrochloride
- Product NDC
- 43975-266
- 11-digit product format
- 439750266
- Labeler code
- 43975
- Product ID
- 43975-266_b0907384-1fef-433a-9d3b-3bd35bcdc3ee
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Memantine Hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- ANI Pharmaceuticals, Inc.
- Application
- ANDA205365
- Marketing category
- ANDA
- Marketing start
- 2020-05-19
- Marketing end
- 0000-00-00
- Substance
- MEMANTINE HYDROCHLORIDE
- Active strength
- 28 mg/1
- Pharmacologic classes
- N-methyl-D-aspartate Receptor Antagonist [EPC], NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43975-266-03 | 43975026603 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43975-266-03) | 2020-05-19 | 0000-00-00 | No | No | Current |
| 43975-266-09 | 43975026609 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43975-266-09) | 2020-05-19 | 0000-00-00 | No | No | Current |